BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Leão I, Marinho J, Costa T. Long-term response to avelumab and management of oligoprogression in Merkel cell carcinoma: A case report. World J Clin Cases 2021; 9(18): 4829-4836 [PMID: 34222455 DOI: 10.12998/wjcc.v9.i18.4829]
URL: https://www.wjgnet.com/1007-9327/full/v9/i18/4829.htm
Number Citing Articles
1
Gianluca Ferini, Valentina Zagardo, Paola Critelli, Anna Santacaterina, Serena Sava, Mandara Muralidhar Harikar, Tejas Venkataram, Giuseppe Emmanuele Umana, Anna Viola, Vito Valenti, Stefano Forte. Introducing Radiotherapy in Metastatic Merkel Cell Carcinoma Patients with Limited Progression on Avelumab: An Effective Step against Primary and Secondary Immune Resistance?Journal of Personalized Medicine 2023; 13(5): 841 doi: 10.3390/jpm13050841
2
Avelumab/cisplatin/etoposideReactions Weekly 2021; 1867(1): 75 doi: 10.1007/s40278-021-00135-8